Bolt Biotherapeutics Inc.

NASDAQ: BOLT · Real-Time Price · USD
5.31
-0.13 (-2.39%)
At close: Aug 15, 2025, 12:21 PM

Bolt Biotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
7.69M 7.88M 5.73M 1.26M
Cost of Revenue
n/a 1.88M 4.89M 3.67M
Gross Profit
5.51M 5.99M 838K -2.41M
Operating Income
-73.05M -76.2M -90.32M -92.79M
Interest Income
5.25M 7M 2.22M 281K
Pretax Income
-63.12M -69.2M -88.1M -98.59M
Net Income
-63.12M -69.2M -85.88M -104.39M
Selling & General & Admin
18.46M 22.53M 22.93M 18.39M
Research & Development
57.47M 61.54M 73.12M 75.66M
Other Expenses
4.81M n/a n/a -6.08M
Operating Expenses
80.74M 84.07M 96.05M 94.05M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
80.74M 84.07M 96.05M 94.05M
Income Tax Expense
n/a n/a -2.22M 5.8M
Shares Outstanding (Basic)
38.18M 37.81M 37.36M 37.4M
Shares Outstanding (Diluted)
38.18M 37.81M 37.36M 37.4M
EPS (Basic)
-1.65 -1.83 -2.3 -2.79
EPS (Diluted)
-1.65 -1.83 -2.3 -2.79
EBITDA
-66.45M -74.34M -88.66M -91.59M
EBIT
-68.24M -76.2M -90.32M -92.79M
Depreciation & Amortization
1.78M 1.85M 4.89M 3.67M